Avantax Planning Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Avantax Planning Partners's BSX Position: Q2 2026 in Review
Avantax Planning Partners reduced its Boston Scientific (BSX) stake by 6.7% in Q2 2026, selling an estimated $19K and leaving 4,892 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #438.
Avantax Planning Partners first reported a position in BSX in Q3 2017 and has held it in 18 quarters since. The position peaked at $515K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Avantax Planning Partners held 4,892 shares of Boston Scientific worth $209K as of Q2 2026.
- Avantax Planning Partners sold 350 Boston Scientific shares in Q2 2026, an estimated $19K.
- Boston Scientific made up 0.01% of Avantax Planning Partners's portfolio in Q2 2026, its #438 holding.
- Avantax Planning Partners first reported a position in Boston Scientific in Q3 2017 and has held it in 18 quarters since.
- Avantax Planning Partners's Boston Scientific position peaked at $515K in Q2 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Avantax Planning Partners's 13F filing for Q2 2026, filed 28 Jul 2026.